腰大肌大小预测外科主动脉瓣置换术后风险校正结局
本研究从机构数据库提取2009至2016年240例中高危(预测死亡率大于3%)行外科主动脉瓣置换术(伴或不伴冠状动脉旁路移植)的患者,以L4椎体水平腰大肌横截面积经体表面积归一化计算腰大肌指数,并按性别特异性第25百分位以下定义肌少症。结果显示肌少症患者1年死亡率更高(31.9% vs 16.9%,p=0.03),腰大肌指数可预测风险校正的1年死亡率(OR 0.84,p=0.02)和长期死亡率(HR 0.92,p=0.04)。作者认为腰大肌指数是易于获取且可重复的衰弱指标,可能改善高危主动脉瓣疾病患者的手术选择和风险校正。
要点
- 肌少症患者1年死亡率为31.9%,无肌少症者为16.9%(p=0.03)。
- 腰大肌指数预测风险校正1年死亡率OR 0.84(p=0.02)。
- 腰大肌指数预测风险校正长期死亡率HR 0.92(p=0.04)。
核心结论
- 腰大肌指数是易于获取且可重复的衰弱指标,可预测风险校正的资源利用、并发症和长期死亡率。
- 腰大肌指数可能改善高危主动脉瓣疾病患者的手术选择和风险校正。
研究设计与样本
- 从机构数据库(2009至2016年)提取中高危(预测死亡率大于3%)行外科主动脉瓣置换术伴或不伴冠状动脉旁路移植的患者240例。
- 腰大肌指数按L4椎体水平腰大肌横截面积经体表面积归一化计算。
- 肌少症定义为腰大肌指数低于性别特异性第25百分位。
- 采用多变量回归分析,使用胸外科医师学会预测风险评分评估腰大肌指数与风险校正结局的关联。
主要发现
- 240例患者中位预测死亡率6%,中位年龄80岁,女性占40%。
- 肌少症患者占33.3%,无肌少症者占66.7%,两组基线风险相当(中位预测死亡率5.7% vs 6.0%,p=0.29)。
- 肌少症患者1年死亡率高于无肌少症者(31.9% vs 16.9%,p=0.03)。
- 腰大肌指数显著预测风险校正1年死亡率(OR 0.84,p=0.02)和长期死亡率(HR 0.92,p=0.04)。
- 腰大肌指数还预测风险校正的主要并发症、延长通气、住院时间、出院至机构及住院费用。
临床怎么用
- 作者认为腰大肌指数可能改善高危主动脉瓣疾病患者的手术选择和风险校正。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Frailty is an important predictor of outcomes after cardiac surgery, but utility is limited by difficult assessment and quantification. We hypothesize that sarcopenia defined as psoas muscle cross-sectional area is a useful predictor of surgical aortic valve replacement outcomes in moderate to high-risk patients. METHODS: Moderate to high risk patients (predicted risk of mortality greater than 3%) who underwent surgical aortic valve replacement with or without coronary artery bypass were extracted from an institutional database (2009 to 2016). Psoas index was calculated as the cross-sectional area of the psoas muscle at the L4 vertebral level normalized to body surface area. Patients were stratified by sarcopenia status, defined as less than 25th sex-specific percentile. Multivariable regression analysis identified risk-adjusted associations with psoas index using The Society of Thoracic Surgeons predicted risk scores. RESULTS: Of the 240 patients included, the median predicted risk of mortality was 6%, median age 80 years, and 40% were female. Patients with (33.3%) and without (66.7%) sarcopenia had equivalent baseline risk (median predicted risk of mortality 5.7% versus 6.0%, p = 0.29). Patients with sarcopenia had higher 1-year mortality (31.9% versus 16.9% p = 0.03). Psoas index significantly predicted risk-adjusted 1-year mortality (odds ratio 0.84, p = 0.02) and long-term mortality (hazard ratio 0.92, p = 0.04), as well as risk-adjusted major morbidity, prolonged ventilation, length of stay, discharge to a facility, and hospital cost. Finally, psoas index measurements were highly reproducible (Pearson correlation coefficient 0.944). CONCLUSIONS: Psoas index is an easily obtained and reproducible measure of frailty that predicts risk-adjusted resource utilization, morbidity, and long-term mortality. Psoas index may improve procedural selection and risk adjustment in high-risk patients with aortic valve disease.
引用
- Hawkins RB, Mehaffey JH, Charles EJ, et al. Psoas Muscle Size Predicts Risk-Adjusted Outcomes After Surgical Aortic Valve Replacement. Ann Thorac Surg. 2018. PMID: 29530777. doi:10.1016/j.athoracsur.2018.02.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。